Revere Asset tweaks small holdings
- Revere Asset Management’s latest 13F shows a new Cameco stake and a bigger Micron position in the quarter ended December 31, 2025. - The specific adds were 54,162 Cameco shares worth about $4.96 million and 8,574 extra Micron shares, lifting that stake to 11,891. - So the story is not a Micron trim at all — it’s a small uranium-and-memory add inside a portfolio still dominated by leveraged S&P bets.
The news here is a fund-filing reality check. Revere Asset Management did add Cameco, the uranium miner. But it did not trim Micron in its latest disclosed 13F. It increased Micron instead. The filing covers positions held on December 31, 2025, and it was submitted to the SEC on February 9, 2026. (sec.gov) ### What actually changed? Revere opened a new Cameco position of 54,162 shares, valued at roughly $4.96 million at quarter-end. In the same filing, Micron shows up as 11,891 shares worth about $3.39 million, up by 8,574 shares from the prior quarter. So if you started from the idea that Revere sold into a semiconductor rally, the filing says otherwise. (holdingschannel.com) ### How big are those moves? They are real, but they are small. Cameco was about 1.74% of the disclosed 13F portfolio. Micron was about 1.19%. Revere’s whole reported 13F book was about $284.1 million, spread across 34 line items, so neither position belongs in the “core holding” bucket. (fintel.io) still an index-and-leverage-heavy portfolio. The biggest holdings were SPDR Portfolio S&P 500 ETF, ProShares Ultra S&P500, ProShares UltraPro S&P500, and Direxion Daily S&P 500 Bull 2X ETF. Those positions dwarf Cameco and Micron. Eli Lilly and SPDR Gold Shares were also much larger than either of the two names in this story. (holdingschannel.com) ### Why does Cameco stand out anyway? Because it fits a very specific side bet. Cameco gives Revere direct exposure to uranium, nuclear fuel demand, and the broader nuclear-power trade without making it a top portfolio theme. The same filing also shows a new position in the rare-earths ETF REMX and a position in the l(holdingschannel.com)st materials-and-hard-assets sleeve. (holdingschannel.com) ### What about the tech side? Revere was not backing away from tech across the board. The filing added or increased names like Alphabet, Rocket Lab, Astera Labs, Teradyne, and Sandisk, while also cutting Nvidia and Tesla. That mix looks more like selective reshuffling than a clean rotation out of growth. One pocket got trimmed, another got funded. (holdingschannel.com) ### Can you read sector flows from this? Only carefully. A single manager’s small 13F changes are more like footprints than a map. They can hint at what an investor is testing — in this case, a little more uranium, a little more memory, some gold and rare-earth exposure — but they do not prove a broad institutional sh(holdingschannel.com) holdings as of December 31, 2025. (sec.gov) ### Why does the date matter so much? Because people often read a fresh filing as fresh trading. It isn’t. The document hit the SEC in February 2026, but the positions are quarter-end holdings from late 2025. Revere could have changed the book since then. So the clean takeaway is narrow: the latest disclosed filing shows a new Cameco stake and a larger Micron stake, not a Micron trim. (sec.gov) ### Bottom line This story matters mostly because the original framing was off. Revere did make a small uranium bet through Cameco. But the more important correction is that Micron was added to, not cut — and both moves sat inside a much bigger, still very bullish U.S. equity portfolio. (holdingschannel.com)
